All Articles: COVID-19

Proteins of highly pathogenic viruses, such as SARS-CoV-2 that causes COVID-19 disease, play a critical role in the body’s immune response to infection, sometimes causing overt inflammation and tissue damage.

Social distancing can help deter some of COVID-19’s spread, but the development of a vaccine is the only surefire way to combat this devastating disease.

Montserrat Torremorell, DVM, PhD, is collaborating with researchers both within the CVM and at the College of Science and Engineering to test whether air purifying systems can inactivate airborne coronaviruses.

Human pulmonary epithelial cells, which serve many important functions in human lungs, express two key enzymes, ACE2 and TMPRSS2, that help SARS-CoV-2, the virus that causes COVID-19, enter human p

The COVID-19 outbreak has crystallized the urgent need for therapeutics to better prevent transmission in human populations.

Coronaviruses infect humans by binding to specific proteins, known as receptors, on human cell surfaces.

A study led by Mythili Dileepan, PhD, will use non-infectious virus-like particles to create a vaccine for COVID-19

As shelter-in-place mandates lessen, societies may be able to reopen parts of their economies while still curbing overall disease spread by limiting interactions related to increased disease.

Using both commercial reference material and potential clinical samples from the University of Minnesota Medical School, Lions Gift of Sight, and Veterinary Medical Center, a team of researchers led by Declan Schroeder, PhD, will convert a targeted next-generation sequencing approach (that was developed in-house) to sequence SARS-CoV-2, the virus that causes COVID-19.

Professor Fang Li recently published, "Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain," in Nature Communications.